An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis

Abstract Background The study aimed to establish a prognostic survival model with 8 pyroptosis-and-cuproptosis-related genes to examine the prognostic effect in patients of hepatocellular carcinoma (HCC). Methods We downloaded gene expression data and clinical information of HCC patients from The Ca...

Full description

Bibliographic Details
Main Authors: Hongjin Wang, Nian Wang, Ze Tang, Qiuyu Liu, Shiyu Nie, Wu Tao
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Hereditas
Subjects:
Online Access:https://doi.org/10.1186/s41065-023-00288-7
_version_ 1797774140171616256
author Hongjin Wang
Nian Wang
Ze Tang
Qiuyu Liu
Shiyu Nie
Wu Tao
author_facet Hongjin Wang
Nian Wang
Ze Tang
Qiuyu Liu
Shiyu Nie
Wu Tao
author_sort Hongjin Wang
collection DOAJ
description Abstract Background The study aimed to establish a prognostic survival model with 8 pyroptosis-and-cuproptosis-related genes to examine the prognostic effect in patients of hepatocellular carcinoma (HCC). Methods We downloaded gene expression data and clinical information of HCC patients from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and Gene Expression Omnibus (GEO). The clustering analysis and cox regression with LASSO were used for constructing an 8 PCmRNAs survival model. Using TCGA, ICGC and GEO cohort, the overall survival (OS) between high- and low- risk group was determined. We also evaluated independent prognostic indicators using univariate and multivariate analyses. The relatively bioinformatics analysis, including immune cell infiltration, function enrichment and drug sensitivity analyses, was performed as well. The gene expression of 8 PCmRNAs in vitro were validated in several HCC cell lines by qRT-PCR and Western blot. The relationship between GZMA and Fludarabine were further checked by CCK-8 assay. Results The survival prognostic model was constructed with ATP7A, GLS, CDKN2A, BAK1, CHMP4B, NLRP6, NOD1 and GZMA using data from TCGA cohort. The ICGC and GEO cohort were used for model validation. Receiver operating characteristic (ROC) curves showed a good survival prediction by this model. Risk scores had the highest predictable value for survival among Stage, Age, Gender and Grade. Most Immune cells and immune functions were decreased in high-risk group. Besides, function enrichment analyses showed that steroid metabolic process, hormone metabolic process, collagen − containing extracellular matrix, oxidoreductase activity and pyruvate metabolism were enriched. Potential drugs targeted different PCDEGs like Nelarabine, Dexamethasone and Fludarabine were found as well. ATP7A, GLS, CDKN2A, BAK1, CHMP4B, NOD1 were upregulated while NLRP6 and GZMA were downregulated in most HCC cell lines. The potential therapy of Fludarabine was demonstrated when GZMA was low expressed in Huh7 cell line. Conclusion We constructed a novel 8-gene (ATP7A, GLS, CDKN2A, BAK1, CHMP4B, NLRP6, NOD1 and GZMA) prognostic model and explored potential functional information and microenvironment of HCC, which might be worthy of clinical application. In addition, several potential chemotherapy drugs were screened and Fludarabine might be effective for HCC patients whose GZMA was low expressed.
first_indexed 2024-03-12T22:16:38Z
format Article
id doaj.art-32cdbdd5da694115a04d9be5fcb8e769
institution Directory Open Access Journal
issn 1601-5223
language English
last_indexed 2024-03-12T22:16:38Z
publishDate 2023-07-01
publisher BMC
record_format Article
series Hereditas
spelling doaj.art-32cdbdd5da694115a04d9be5fcb8e7692023-07-23T11:16:22ZengBMCHereditas1601-52232023-07-01160111510.1186/s41065-023-00288-7An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosisHongjin Wang0Nian Wang1Ze Tang2Qiuyu Liu3Shiyu Nie4Wu Tao5Department of Critical Care Medicine, Yongchuan Hospital, Chongqing Medical UniversityDepartment of Critical Care Medicine, Yongchuan Hospital, Chongqing Medical UniversityDepartment of Critical Care Medicine, Yongchuan Hospital, Chongqing Medical UniversityDepartment of Critical Care Medicine, Yongchuan Hospital, Chongqing Medical UniversityDepartment of Critical Care Medicine, Yongchuan Hospital, Chongqing Medical UniversityDepartment of Critical Care Medicine, Yongchuan Hospital, Chongqing Medical UniversityAbstract Background The study aimed to establish a prognostic survival model with 8 pyroptosis-and-cuproptosis-related genes to examine the prognostic effect in patients of hepatocellular carcinoma (HCC). Methods We downloaded gene expression data and clinical information of HCC patients from The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and Gene Expression Omnibus (GEO). The clustering analysis and cox regression with LASSO were used for constructing an 8 PCmRNAs survival model. Using TCGA, ICGC and GEO cohort, the overall survival (OS) between high- and low- risk group was determined. We also evaluated independent prognostic indicators using univariate and multivariate analyses. The relatively bioinformatics analysis, including immune cell infiltration, function enrichment and drug sensitivity analyses, was performed as well. The gene expression of 8 PCmRNAs in vitro were validated in several HCC cell lines by qRT-PCR and Western blot. The relationship between GZMA and Fludarabine were further checked by CCK-8 assay. Results The survival prognostic model was constructed with ATP7A, GLS, CDKN2A, BAK1, CHMP4B, NLRP6, NOD1 and GZMA using data from TCGA cohort. The ICGC and GEO cohort were used for model validation. Receiver operating characteristic (ROC) curves showed a good survival prediction by this model. Risk scores had the highest predictable value for survival among Stage, Age, Gender and Grade. Most Immune cells and immune functions were decreased in high-risk group. Besides, function enrichment analyses showed that steroid metabolic process, hormone metabolic process, collagen − containing extracellular matrix, oxidoreductase activity and pyruvate metabolism were enriched. Potential drugs targeted different PCDEGs like Nelarabine, Dexamethasone and Fludarabine were found as well. ATP7A, GLS, CDKN2A, BAK1, CHMP4B, NOD1 were upregulated while NLRP6 and GZMA were downregulated in most HCC cell lines. The potential therapy of Fludarabine was demonstrated when GZMA was low expressed in Huh7 cell line. Conclusion We constructed a novel 8-gene (ATP7A, GLS, CDKN2A, BAK1, CHMP4B, NLRP6, NOD1 and GZMA) prognostic model and explored potential functional information and microenvironment of HCC, which might be worthy of clinical application. In addition, several potential chemotherapy drugs were screened and Fludarabine might be effective for HCC patients whose GZMA was low expressed.https://doi.org/10.1186/s41065-023-00288-7Hepatocellular carcinomaPrognostic modelPyroptosisCuproptosisBioinformatics
spellingShingle Hongjin Wang
Nian Wang
Ze Tang
Qiuyu Liu
Shiyu Nie
Wu Tao
An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis
Hereditas
Hepatocellular carcinoma
Prognostic model
Pyroptosis
Cuproptosis
Bioinformatics
title An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis
title_full An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis
title_fullStr An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis
title_full_unstemmed An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis
title_short An 8-gene predicting survival model of hepatocellular carcinoma (HCC) related to pyroptosis and cuproptosis
title_sort 8 gene predicting survival model of hepatocellular carcinoma hcc related to pyroptosis and cuproptosis
topic Hepatocellular carcinoma
Prognostic model
Pyroptosis
Cuproptosis
Bioinformatics
url https://doi.org/10.1186/s41065-023-00288-7
work_keys_str_mv AT hongjinwang an8genepredictingsurvivalmodelofhepatocellularcarcinomahccrelatedtopyroptosisandcuproptosis
AT nianwang an8genepredictingsurvivalmodelofhepatocellularcarcinomahccrelatedtopyroptosisandcuproptosis
AT zetang an8genepredictingsurvivalmodelofhepatocellularcarcinomahccrelatedtopyroptosisandcuproptosis
AT qiuyuliu an8genepredictingsurvivalmodelofhepatocellularcarcinomahccrelatedtopyroptosisandcuproptosis
AT shiyunie an8genepredictingsurvivalmodelofhepatocellularcarcinomahccrelatedtopyroptosisandcuproptosis
AT wutao an8genepredictingsurvivalmodelofhepatocellularcarcinomahccrelatedtopyroptosisandcuproptosis
AT hongjinwang 8genepredictingsurvivalmodelofhepatocellularcarcinomahccrelatedtopyroptosisandcuproptosis
AT nianwang 8genepredictingsurvivalmodelofhepatocellularcarcinomahccrelatedtopyroptosisandcuproptosis
AT zetang 8genepredictingsurvivalmodelofhepatocellularcarcinomahccrelatedtopyroptosisandcuproptosis
AT qiuyuliu 8genepredictingsurvivalmodelofhepatocellularcarcinomahccrelatedtopyroptosisandcuproptosis
AT shiyunie 8genepredictingsurvivalmodelofhepatocellularcarcinomahccrelatedtopyroptosisandcuproptosis
AT wutao 8genepredictingsurvivalmodelofhepatocellularcarcinomahccrelatedtopyroptosisandcuproptosis